At two upcoming events on rare disease clinical trials and data management, experts will dissect the latest trends and ...

In 2021, the Government of India established Centres of Excellence (CoEs) under the National Policy for Rare Diseases to ...

Continuing our rare disease theme, Catherine McLoughlin shares her thoughts on the orphan drug market and how pharma / biotech companies may change their focus to rare diseases in the future.

Enzo Porrello said he is working to develop stem cell treatments that can target the root cause of heart disease to ...

Last night, the Arabian nights of Riyadh offered a glamorous and enchanting spectacle. Elie Saab presented an extraordinary ...

Amgen, a global biotechnology leader highlighting profound research and development capabilities and biomanufacturing, showcases its latest achievements in the field of innovative medicines under the ...

Capito joined Will Ahmed (co-founder and CEO of WHOOP), Joshua Fink (founder of Luma Group), Morad Fareed (founder of Delos and FC Mother), and Nisa Leung (managing partner, Qiming Venture Partners) ...

At the CIIE, Amgen brings six innovative products-focusing on cardiovascular, bone health, oncology, inflammation and rare diseases-each precisely tailored to the unmet needs of Chinese patients.

An estimated 17. 9 million people die every year worldwide from cardiovascular diseases, making it the lead cause for deaths ...

11.3. The Advisory Committee recommended that avalglucosidase alfa for the treatment of late onset Pompe disease be funded with a medium priority.